Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Dopaminergic Mechanisms of Slowing to Improve Late Life Depression

NCT03761030 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT03761030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03761030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Dopaminergic Mechanisms of Slowing to Improve Late Life Depression
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Terminated
Start date
January 9, 2019
Completion date
September 8, 2021
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, dysthymia, major depressive disorder